ArticleThe Journal of urology2010

A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer.

William D Figg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.